Vector-Borne Disease Research
ATCC houses numerous microorganisms and nucleic acids to support research on vector-borne pathogens such as Dengue virus, West Nile virus, and Borrelia burgdorferi.
Billions of people worldwide are at risk from microorganisms transmitted by mosquitoes, ticks, fleas, and other vectors. Due to the complexity of vector-borne pathogen transmission and the unpredictable nature of insect vectors, vector-borne illnesses are among the most difficult infectious diseases to predict, prevent, and control.
The development of rapid diagnostic tools and innovative vaccines is essential for improving patient outcomes and preventing the further emergence and spread of disease. To aid in these efforts, ATCC offers an array of microorganisms and nucleic acids to support research on prevalent vector-borne diseases such as:
- Chagas disease
- Dengue fever
- Lyme disease
- Rocky Mountain spotted fever
- West Nile fever
ATCC Genuine Cultures® and ATCC® Genuine Nucleics are high-quality, authenticated materials ideal for use as reference standards in the development and evaluation of vaccines, novel therapeutics, and diagnostic tools.
Check out the resources below to learn more.
The WHO estimates that vector-borne diseases contribute to 17% of the estimated global burden of infectious diseases. To aid in vector-borne research, ATCC has compiled a collection of microbial species known to be transmitted by insect vectors. Search for strains by product category:
The development and evaluation of rapid diagnostic methods is critical for the detection and effective treatment of vector-borne pathogens. ATCC offers an expanding collection of native and synthetic nucleic acids to support vector-borne research.
Find nucleic acids
Need an affordable solution to nucleic acid extractions, scaled-up production, or manufacturing? ATCC can help with customized services and solutions to meet your specific vector-borne research needs.